IRD Competitors & Alternatives
Compare Opus Genetics, Inc. with similar stocks in the same industry
Biotechnology
IRD
Main Stock$4.00
Tradestie Score
55
Market Cap
$107.83M
Revenue Growth
-0.5%
Analyst Upside
+161.3%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$10.14
|
$371.64M | - | 53 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$29.89
|
$357.51M | - | 56 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$18.25
|
$354.45M | - | 60 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$31.67
|
$353.70M | - | 58 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.74
|
$350.98M | - | 62 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.01
|
$341.56M | - | 59 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.49
|
$332.96M | - | 53 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.59
|
$328.62M | - | 63 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.43
|
$304.12M | - | 61 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$22.41
|
$297.23M | - | 50 | Compare |
More IRD Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry